Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUINIX INCEQIX · Entity 2047 | Director | May 25, 2022 | May 26, 2022 |
| EXPRESS SCRIPTS INCESRX · Entity 167429 | Sr. VP and Chief Info. Officer | April 16, 2018 | April 20, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUINIX INC
Report date May 25, 2022 · Filed May 26, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 209 |
Reported balance
After 2022-05-26 transaction · row 1
1 source rowRow 1 · 2022-05-26 · Exercise / conversion · Acquired 209 · Balance 209 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 364 |
Reported balance
After 2022-05-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-05-25 · Grant · Acquired 364 · Balance 364 F1: The Restricted Stock Units shall vest on the earlier of (i) May 25, 2023 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2: Restricted stock unit award expires upon reporting person's termination of service. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-05-26 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-26 · Exercise / conversion · Disposed 209 · Balance 0 F3: The Restricted Stock Units shall vest on the earlier of (i) May 26, 2022 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2: Restricted stock unit award expires upon reporting person's termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units shall vest on the earlier of (i) May 25, 2023 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date.
F2: Restricted stock unit award expires upon reporting person's termination of service.
F3: The Restricted Stock Units shall vest on the earlier of (i) May 26, 2022 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date.
EXPRESS SCRIPTS INC
Report date April 16, 2018 · Filed April 20, 2018
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Express Scripts Holding Co.
Report date December 20, 2018 · Filed December 21, 2018
Section 16 reporting ended · disclosed 2018-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-12-20 transaction · row 1
1 source rowRow 1 · 2018-12-20 · Disposition to issuer · Disposed 10,199 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2022 Filed May 26, 2022 21:39 UTC | EQUINIX INC EQIX · Entity 2047 | Exercise / conversionRestricted Stock Unit · Derivative | 209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015791 · form4.xml · derivative · entry 3 Guerrier Ron · CIK 0001737696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 209 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 26, 2022 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| May 26, 2022 Filed May 26, 2022 21:39 UTC | EQUINIX INC EQIX · Entity 2047 | Exercise / conversionCommon Stock | 209 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015791 · form4.xml · nonDerivative · entry 1 Guerrier Ron · CIK 0001737696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:39 UTC | EQUINIX INC EQIX · Entity 2047 | GrantRestricted Stock Unit · Derivative | 364 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015791 · form4.xml · derivative · entry 2 Guerrier Ron · CIK 0001737696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364 Underlying: Common Stock · 364 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 25, 2023 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| September 11, 2021 Filed Sep 15, 2021 00:04 UTC | EQUINIX INC EQIX · Entity 2047 | GrantRestricted Stock Unit · Derivative | 209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-025275 · form4.xml · derivative · entry 1 Guerrier Ron · CIK 0001737696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 Underlying: Common Stock · 209 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 26, 2022 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 16:35 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | Disposition to issuerCommon Stock | 10,199 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000677 · edgar.xml · nonDerivative · entry 1 Guerrier Ron · CIK 0001737696 · Sr. VP and Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the "Merger"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a unit with respect to common stock of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. Read SEC document |
| May 09, 2018 Filed May 11, 2018 16:37 UTC | Express Scripts Holding Co. ESRX · Entity 161583 | GrantCommon Stock | 10,199 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000364 · edgar.xml · nonDerivative · entry 1 Guerrier Ron · CIK 0001737696 · Sr. VP and Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,199 F1 · price: Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on May 9, 2019, May 9, 2020, and May 9, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.